Tarsus Pharmaceuticals, Inc. (TARS) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Tarsus Pharmaceuticals, Inc.
Address
15440 Laguna Canyon Road
Irvine, CA 92618
United States of America (the)
Phone
949 409 9820
Website
Sector
Healthcare
Industry
Biotechnology
Employees
370
First IPO Date
October 16, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Bobak R. Azamian | Co-Founder, President, Chief Executive Officer & Chairman | 1.32M | N/A |
| Elizabeth Yeu | Chief Medical Officer | 156,691 | 1978 |
| Dianne C. Whitfield | Chief Human Resources Officer | 578,900 | 1977 |
| Bryan Wahl | General Counsel & Corporate Secretary | 771,233 | 1978 |
| Aziz Mottiwala | Chief Commercial Officer | 821,650 | 1978 |
| Seshadri Neervannan | Chief Operating Officer | 839,200 | 1968 |
| Jeffrey S. Farrow | Chief Financial Officer & Chief Strategy Officer | 888,645 | 1962 |
| Adrienne Kemp | Vice President of Corporate Communications | 0 | N/A |
| Scott Youmans | Vice President of Sales | 0 | N/A |
| Cara Miller | Senior Vice President of Corporate Affairs | 0 | N/A |
| Neera Clase | Senior Vice President of Market Access | 0 | N/A |
| David Nakasone | Head of Investor Relations | 0 | N/A |
| Matthew Rossen | Vice President of Marketing | 0 | 1978 |
Description
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
